iReliev

Overview

iReliev is the value entry point of the FDA-registered EMS market. Manufactured by Excel Health LLC out of Dallas/Fort Worth, Texas (founded 2012), the flagship ET-7070 combo TENS + EMS device combines pain-relief and muscle-stimulation functionality in a credit-card-sized form factor priced under $100. At that price, no competing FDA-registered device offers the same program count, channel count, or claimed output intensity.

The ET-7070 is a dual-channel device: two independent output channels drive up to four electrode pads simultaneously — two pads per channel — which means you can target two different muscle groups or run a bilateral protocol (both sides of the body) in one session without moving pads. 14 preset programs split between 8 TENS programs (targeting pain-signal modulation) and 6 EMS programs (targeting muscle contraction and conditioning), with 25 intensity levels and a lock function to prevent accidental adjustments during a session.

Rx-equivalent output intensity is iReliev’s core marketing claim — the idea that the device delivers stimulation intensity comparable to what a physical therapist or clinic would administer. We have not independently bench-tested this claim; it remains unverified until we test a unit on the bench.

Capabilities

TENS (Transcutaneous Electrical Nerve Stimulation) programs deliver low-frequency electrical pulses designed to modulate pain perception. The 8 TENS programs in the ET-7070 cover a range of stimulation patterns commonly used for pain management. TENS devices at this category are used for temporary relief of chronic and acute pain; they are not treatments for underlying conditions.

EMS (Electrical Muscle Stimulation) programs deliver higher-frequency stimulation designed to produce involuntary muscle contractions. The 6 EMS programs cover general conditioning and recovery applications. Compared with Compex Sport Elite’s sport-specific phase-based programs or PowerDot Duo Pro’s AR-guided discipline protocols, the iReliev EMS library is general-purpose — appropriate for most users but without the athletic-periodization depth of higher-tier devices.

The credit-card form factor is a practical differentiator: the ET-7070 fits in a pocket, travels easily, and does not require a bag or case for portability. The tradeoff is the AAA-battery dependency on the base unit — the ET-7070 uses disposable batteries rather than a rechargeable lithium pack. Heavy users will factor ongoing battery cost into the TCO.

iReliev also offers a wireless wearable model in its lineup — a pod-based format for users who want cable-free sessions. This is a separate product from the ET-7070 and sits at a higher price point within the iReliev range.

Tradeoffs

iReliev’s value proposition is uncomplicated: maximum program coverage and output intensity per dollar spent, with no subscription and no app required to operate the device. The base unit works entirely from its physical controls. For users who want data tracking, session logging, or connected coaching, the absence of a smartphone app is a real limitation.

No sport-specific programs is the most significant capability gap relative to higher-tier devices. Compex Sport Elite has programs calibrated to specific sports and training phases (warm-up, strength, endurance, recovery, pre-competition). PowerDot Duo Pro maps protocols by discipline with AR-guided placement. iReliev’s programs are general-purpose — TENS for pain, EMS for stimulation — without the periodization structure an athlete using EMS as part of a training protocol would want.

Build quality is the other consistent tradeoff: the ET-7070’s plastic construction is functional but not premium. At sub-$100, this is expected; users who plan long-term daily use should evaluate whether the build suits that cadence.

No clinical-grade output verification is in place from our side. The “Rx-equivalent output” claim is what the brand asserts; our bench test is pending.

Regulatory status

iReliev devices are FDA-registered. FDA registration means the establishment and devices appear in the FDA’s device database, which is required for selling electrical stimulation devices in the United States. Registration is distinct from 510(k) clearance. No 510(k) K-number is documented in brand data for the iReliev lineup. As with all consumer TENS/EMS devices, iReliev products are wellness and muscle-conditioning tools, not medical devices for treating specific conditions.

3-year cost of ownership

Component	iReliev ET-7070	PowerDot 2.0	Beurer EM95	Compex Sport Elite
Hardware	~$50–$100	~$269	~$300–$400	~$799
Subscription	$0	$0	$0	$0
Batteries (annual)	Moderate (AAA)	$0 (rechargeable)	$0 (rechargeable)	$0 (rechargeable)
3-year hardware	~$50–$100	~$269	~$300–$400	~$799

On hardware alone, iReliev is 5–16x cheaper than category alternatives. The AAA-battery ongoing cost partially offsets this for heavy users; the rechargeable models up the range do not carry this cost.

Where it fits

• Strong fit: First-time EMS users exploring the category without a large commitment, budget-priority buyers who want both TENS pain management and EMS muscle stimulation in a single device, travelers who need a portable ultra-compact device, and users who prefer simple physical controls without app dependency.
• Weaker fit: Elite athletes who need sport-specific protocol structure (Compex Sport Elite), Therabody ecosystem users (PowerDot), full-body simultaneous coverage (Beurer EM95), or clinical / DC neuromuscular protocols (NeuFit Neubie).

Verdict: Recommended

iReliev earns a recommended verdict as the clearest value-first option in the FDA-registered EMS/TENS category. At sub-$100 with 14 programs, 25 intensity levels, and dual-channel 4-pad coverage in a pocket-sized device, it delivers more capability per dollar than any competitor at this price. The caveats are appropriately sized: no app, AAA batteries, plastic build, and general-purpose rather than sport-specific programs. For the buyer whose priorities are cost, portability, and combined TENS+EMS coverage, iReliev is the structurally correct first choice.

How we’ll test this

Hands-on testing is pending. When a unit is on the bench, we will verify the claimed output intensity, evaluate TENS and EMS program performance against the published spec, and measure how the credit-card form factor handles repeated use. See our methodology.

Changelog

• 2026-06-15: Expanded review — corrected FDA status from “510(k) cleared for both TENS and EMS indications” to “FDA-registered” per brand YAML (no K-number documented), surfaced ET-7070 model name and spec detail (14 programs / 8 TENS + 6 EMS / 25 intensity levels / dual-channel / AAA-battery), added wireless wearable model note, built TCO table with battery-cost caveat, added Where-It-Fits and How-We’ll-Test sections. Hands-on testing still pending.
• 2026-05-07: Initial review published based on iReliev published specifications.